WellDoc

The company develops mobile solutions to drive behavioral and clinical change in chronic disease. WellDoc’s goal is to improve patient self-management and help physicians overcome gaps in the delivery system to improve clinical outcomes and decrease cost. WellDoc is best known for its flagship product BlueStar, which is a digital therapeutic for adults with type 2 diabetes.

Welldoc home

Welldoc, Redox team-up to optimize provider interaction with chronic disease management platform

By ensuring bidirectional integration with EHRs and insights available at the point of care, the partnership will help optimize clinical decision support.
Welldoc home

Welldoc’s chronic condition platform expanded to include behavioral health

The new offering complements existing programs for diabetes, hypertension, heart failure and diabetes prevention.
WellDoc app screen

Eli Lilly to integrate Welldoc’s BlueStar app capabilities into its connected insulin solutions

The two companies will collaborate to create a new version of the BlueStar insulin management solution that integrates insulin data for Lilly insulins.